Updated Mar 14, 2018

The traps Kim can spring on Trump

North Korean leader Kim Jong-un attending a military parade. Photo: AFP / KCNA via KNS

Talks with North Korea present a long list possible pitfalls for the U.S. Since Kim Jong-un's offer, President Trump has exacerbated the risks by accepting the invitation outright, issuing overconfident statements and replacing the cautious Rex Tillerson with the pliant Mike Pompeo as secretary of state.

Why it matters: The State Department exists to ensure that the president arrives at summits like this with a strong hand, by nailing down favorable terms and negotiation strategy. Ignoring this expertise will see Trump striding blithely toward potential traps.

Pyongyang's likely gambits:

  1. Strengthen its rule by meeting with Trump on equal footing
  2. Convince Beijing that sanctions are no longer needed
  3. Exacerbate friction in the U.S.-South Korea alliance
  4. Roll back U.S. military presence in Korea
  5. Embarrass Trump by testing missiles before the summit

What's next: So far, the U.S. has only fallen into the first trap — but the others loom. The North Koreans can accomplish the rest by embarrassing Trump and causing him to walk away from the table first. Reneging on their commitment to South Korea to denuclearize could be enough, even if Pyongyang puts a modest but reasonable offer on the table. Or they could maneuver an impulsive president into committing to reduce U.S. forces on the peninsula.

Adam Mount is a senior fellow and director of the Defense Posture Project at the Federation of American Scientists.

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 2 hours ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness the treatment of the novel coronavirus has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow2 hours ago - Health